{"title":"Goblet Cell Adenocarcinoma of the Appendix: Diagnosis, Prognosis and Nomenclature","authors":"Hanlin L. Wang","doi":"10.14218/jctp.2022.00018","DOIUrl":"https://doi.org/10.14218/jctp.2022.00018","url":null,"abstract":"Goblet cell adenocarcinoma (GCA) is a new name for goblet cell carcinoid used by the fifth edition of the World Health Organization Classification of Tumors of the Digestive Sys- tem published in 2019. This name change put an end to the years’ name confusion and led to the simplification and standardization of the diagnostic criteria and grading system for this unique epithelial neoplasm almost exclusively occur- ring in the appendix. This is extremely important because accurate diagnosis and grading are essential to patient man- agement and prognostication. Under this new name, GCA is recognized to have low-grade and high-grade components with variable proportions. As such, the presence of the low-grade components is required for the diagnosis, but the pro- portion of the high-grade components dictates the prognosis. With regard to the nomenclature, GCA does not seem to be an ideal name for this tumor because goblet cells are ap-parently not the cell origin nor the unique cell population of the tumor. While the histogenesis remains ambiguous, the name “crypt","PeriodicalId":73661,"journal":{"name":"Journal of clinical and translational pathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42323496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Immune Checkpoint Inhibitor-Induced Hepatic Injury: A Clinicopathologic Review.","authors":"Mehran Taherian, Deyali Chatterjee, Huamin Wang","doi":"10.14218/jctp.2022.00017","DOIUrl":"10.14218/jctp.2022.00017","url":null,"abstract":"<p><p>Although immune checkpoint inhibitors (ICIs) have been a revolutionary milestone in immuno-oncology, immune-related adverse events (irAEs) may occur due to enhanced T cell activation and immune dysregulation. The irAEs can occur as early as within days to reportedly as late as up to 26 weeks. They may affect any organ system in the body, most commonly the luminal gastrointestinal tract, liver, skin, endocrine system, and lungs. The mechanisms of irAEs are complex and have not been fully understood. A breach of self-tolerance, which leads to autoantigen reactivity due to the enhanced activation and infiltration of T cells or the production of autoantibodies, and a non-specific autoinflammatory mechanism have been proposed. Limited data is available on the clinical and pathologic features of ICI-induced liver injury. This review presents an overview of the clinical and common histopathologic features and patterns of ICI-induced liver injury, the differential diagnoses, and the clinical management. Available data suggest that the histopathologic findings of ICI-induced hepatic injury are often non-specific and overlap with other challenging differential diagnoses. Therefore, a good knowledge of the histopathologic spectrum of ICI-induced hepatic injury and their differential diagnoses combined with the serological test results, clinical correlation, and communication with the clinical team is necessary to make an accurate and timely diagnosis.</p>","PeriodicalId":73661,"journal":{"name":"Journal of clinical and translational pathology","volume":"2 3","pages":"83-90"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/cd/nihms-1844355.PMC9815477.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10514988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Post-infantile Giant Cell Hepatitis: A Literature Review and Meta-analysis.","authors":"Jingjing Jiao, Xuchen Zhang","doi":"10.14218/jctp.2022.00016","DOIUrl":"https://doi.org/10.14218/jctp.2022.00016","url":null,"abstract":"<p><p>Post-infantile giant cell hepatitis (PIGCH) is a rare disease entity in adults with a multifactorial etiology and widely variable clinical courses and outcomes. The factors associated with the worse outcomes of this disease entity are still unclear. We identified 68 PIGCH patients by searching PubMed and performed meta-analysis. Among the 68 patients, 32% of the cases were associated with autoimmune disorders, followed by 21% associated with viral infections, 10% with medication, and 7% with malignancy. Twenty-four percent of the patients had more than one etiological factor, and 6% had other uncommon etiologies or an etiology that could not be identified. At the time of this report, 17 patients had died of the disease (poor outcome), and 51 patients remained alive with the disease (good outcome). Compared to the patients with a good outcome, the patients with a poor outcome were characterized by older age, lower levels of platelets and albumin, higher level of total bilirubin, and a diffuse distribution pattern of giant cells in the liver. There were no differences in gender distribution, aminotransferase, alkaline phosphatase, gamma-glutamyl transferase, etiological distribution, or other histological features, including interface hepatitis, necrosis, lobular inflammation, portal inflammation, cholestasis, or fibrosis. Further studies would be needed to better understand the disease mechanisms and unmask any additional etiological factors and targeted therapies.</p>","PeriodicalId":73661,"journal":{"name":"Journal of clinical and translational pathology","volume":"2 3","pages":"100-107"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/98/c5/nihms-1880187.PMC10117396.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9388705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Histomorphology and Molecular Profiling of Well-Differentiated Squamous Cell Carcinoma of the Esophagus Including its Unusual Variants","authors":"Feng Yin, Wei Zheng, Sam Amofa-Ho, Xiuli Liu","doi":"10.14218/jctp.2022.00019","DOIUrl":"https://doi.org/10.14218/jctp.2022.00019","url":null,"abstract":"","PeriodicalId":73661,"journal":{"name":"Journal of clinical and translational pathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49560006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Practical Issues of Ki-67 Evaluation in Breast Cancer Clinical Practice","authors":"Sean M. Hacking, Yihong Wang","doi":"10.14218/jctp.2022.00012","DOIUrl":"https://doi.org/10.14218/jctp.2022.00012","url":null,"abstract":"","PeriodicalId":73661,"journal":{"name":"Journal of clinical and translational pathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48090003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Follicular Cell Derived Thyroid Carcinoma: Common Things Present in Uncommon Ways","authors":"J. Lai, F. Fang, L. Song, He Wang","doi":"10.14218/jctp.2022.00013","DOIUrl":"https://doi.org/10.14218/jctp.2022.00013","url":null,"abstract":"","PeriodicalId":73661,"journal":{"name":"Journal of clinical and translational pathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47352802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cystic Lung Diseases Causing Spontaneous Pneumothorax","authors":"Chen Zhang","doi":"10.14218/jctp.2022.00011","DOIUrl":"https://doi.org/10.14218/jctp.2022.00011","url":null,"abstract":"Surgical specimens resulting from a spontaneous pneumo- thorax (SP) are commonly encountered in the general surgical pathology practice. Many of the SP cases are primary pneumothorax with no underlying lung diseases. Specimens with primary pneumothorax show nonspecific pneumotho- rax-related changes, which are important to recognize to exclude the true underlying lung diseases. A variety of dis- ease entities may lead to diffuse cystic changes in the lungs, causing secondary pneumothorax. Some of the diseases are progressive and can cause irreversible damage to the lungs if not treated timely. Diagnosis of cystic lung diseases caus- ing secondary pneumothorax is important for the treatment of the diseases and the prevention of future episodes of pneumothorax. Lymphangioleiomyomatosis and Langerhans cell histiocytosis are two common conditions causing diffuse cystic changes in the lungs. They are discussed in greater de-tail in this review, given their overlapping features in patient characteristics, radiological findings, and pathologic findings. a diagnosis of exclusion. Specimens from these patients will show a spectrum of pneumothorax-related changes, which are important to recognize to exclude the true underlying lung diseases. The pneumothorax-related changes include pleural fibrosis with or without blebs, thick-walled blood vessels, and eosinophilic-rich chronic inflammation. 6–8 The underlying lung parenchyma may show distal acinar em-physema and reactive pneumocyte hyperplasia.","PeriodicalId":73661,"journal":{"name":"Journal of clinical and translational pathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46681125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Challenges and Opportunities of Translational Pathology.","authors":"Lanjing Zhang","doi":"10.14218/jctp.2022.00001","DOIUrl":"https://doi.org/10.14218/jctp.2022.00001","url":null,"abstract":"<p><p>Translational pathology has not caught up with the quality and quantity of translational medicine. Thus, challenges and opportunities related to translational pathology are discussed here. Pathologists should actively participate in reverse translational research that seeks mechanistic insights to explain clinical findings and/or solve clinical problems. Challenges in translational pathology include ambiguity in defining translational pathology, pathologists' mindsets about translational research, lack of sufficient workforce and immature publication outlets. However, with collective wisdom and support of various stakeholders, we can expand the pool of pathologist scientists, build a translational pathology community and drive innovations in medicine through computational, molecular genetic/genomic and digital pathology approaches.</p>","PeriodicalId":73661,"journal":{"name":"Journal of clinical and translational pathology","volume":"2 2","pages":"63-66"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/34/ca/nihms-1821291.PMC9302533.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40645312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Differential Diagnosis of High-grade Neuroendocrine Neoplasms in the Digestive System","authors":"Zhaohai Yang","doi":"10.14218/jctp.2022.00008","DOIUrl":"https://doi.org/10.14218/jctp.2022.00008","url":null,"abstract":"","PeriodicalId":73661,"journal":{"name":"Journal of clinical and translational pathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44261208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}